About Ravel Biotechnology
Ravel Biotechnology markets an analytic technology platform capable of early detection of disease from cell-free DNA.The technology platform enables the accelerated development and validation of screening tests for a wide range of diseases from a single analyte, cell-free DNA. Thus providing the opportunity to screen for a multitude of diseasesfrom a single blood draw.The company was co-founded by Erik Gafni and Nathan Boley in 2018 and is based in San Francisco, California.
Founded in 2018 by Erik Gafni and Nathan Boley.
- Founded
- 2018
- Employees
- 11 to 50
- Headquarters
- San Francisco
Leadership
The top of Ravel Biotechnology's org chart, with how many people report into each leader.
NB
Nathan Boley
Co-Founder and CEO
Jobs at Ravel Biotechnology
No open positions right now. Explore more companies on TheJobsMap.